Therapeutic Potential of Glucagon-like Peptide-1 Agonists in Polycystic Ovary Syndrome: From Current Clinical Evidence to Future Perspectives

Despite the continuous effort to understand the pathophysiology and determine potential therapeutic targets, PCOS treatment largely depends on lifestyle intervention and symptomatic management of individual signs and symptoms. International guidelines recognize the importance of weight reduction as...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensterle, Mojca, Herman, Rok, Janež, Andrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405922/
https://www.ncbi.nlm.nih.gov/pubmed/36009535
http://dx.doi.org/10.3390/biomedicines10081989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405922/
https://www.ncbi.nlm.nih.gov/pubmed/36009535
http://dx.doi.org/10.3390/biomedicines10081989

Ejemplares similares